Predicting Survival in Patients with Advanced NSCLC Treated with Atezolizumab Using Pre- and on-Treatment Prognostic Biomarkers.
Saved in:
| Title: | Predicting Survival in Patients with Advanced NSCLC Treated with Atezolizumab Using Pre- and on-Treatment Prognostic Biomarkers. |
|---|---|
| Authors: | Benzekry S; COMPutational Pharmacology and Clinical Oncology Department, Centre Inria de l'Université Côte d'Azur, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France., Karlsen M; COMPutational Pharmacology and Clinical Oncology Department, Centre Inria de l'Université Côte d'Azur, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France., Bigarré C; COMPutational Pharmacology and Clinical Oncology Department, Centre Inria de l'Université Côte d'Azur, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France., Kaoutari AE; COMPutational Pharmacology and Clinical Oncology Department, Centre Inria de l'Université Côte d'Azur, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France., Gomes B; Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Basel, Basel, Switzerland., Stern M; Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Zurich, Zurich, Switzerland., Neubert A; Pharma Research and Early Development, Data & Analytics, Roche Innovation Center Basel, Basel, Switzerland., Bruno R; Modeling and Simulation, Clinical Pharmacology, Genentech Research and Early Development, Marseille, France., Mercier F; Modeling and Simulation, Clinical Pharmacology, Genentech Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Vatakuti S; Pharma Research and Early Development, Predictive Modeling and Data Analytics, Roche Innovation Center Basel, Basel, Switzerland., Curle P; Inovigate, Basel, Switzerland., Jamois C; Pharma Research and Early Development, Translational PKPD and Clinical Pharmacology, Roche Innovation Center Basel, Basel, Switzerland. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Oct; Vol. 116 (4), pp. 1110-1120. Date of Electronic Publication: 2024 Jul 12. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39001619 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Predicting Survival in Patients with Advanced NSCLC Treated with Atezolizumab Using Pre- and on-Treatment Prognostic Biomarkers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Benzekry+S%22">Benzekry S</searchLink>; COMPutational Pharmacology and Clinical Oncology Department, Centre Inria de l'Université Côte d'Azur, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Karlsen+M%22">Karlsen M</searchLink>; COMPutational Pharmacology and Clinical Oncology Department, Centre Inria de l'Université Côte d'Azur, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Bigarré+C%22">Bigarré C</searchLink>; COMPutational Pharmacology and Clinical Oncology Department, Centre Inria de l'Université Côte d'Azur, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Kaoutari+AE%22">Kaoutari AE</searchLink>; COMPutational Pharmacology and Clinical Oncology Department, Centre Inria de l'Université Côte d'Azur, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Gomes+B%22">Gomes B</searchLink>; Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Stern+M%22">Stern M</searchLink>; Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Neubert+A%22">Neubert A</searchLink>; Pharma Research and Early Development, Data & Analytics, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bruno+R%22">Bruno R</searchLink>; Modeling and Simulation, Clinical Pharmacology, Genentech Research and Early Development, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Mercier+F%22">Mercier F</searchLink>; Modeling and Simulation, Clinical Pharmacology, Genentech Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Vatakuti+S%22">Vatakuti S</searchLink>; Pharma Research and Early Development, Predictive Modeling and Data Analytics, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Curle+P%22">Curle P</searchLink>; Inovigate, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jamois+C%22">Jamois C</searchLink>; Pharma Research and Early Development, Translational PKPD and Clinical Pharmacology, Roche Innovation Center Basel, Basel, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2024 Oct; Vol. 116 (4), pp. 1110-1120. <i>Date of Electronic Publication: </i>2024 Jul 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39001619 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpt.3371 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1110 Titles: – TitleFull: Predicting Survival in Patients with Advanced NSCLC Treated with Atezolizumab Using Pre- and on-Treatment Prognostic Biomarkers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Benzekry S – PersonEntity: Name: NameFull: Karlsen M – PersonEntity: Name: NameFull: Bigarré C – PersonEntity: Name: NameFull: Kaoutari AE – PersonEntity: Name: NameFull: Gomes B – PersonEntity: Name: NameFull: Stern M – PersonEntity: Name: NameFull: Neubert A – PersonEntity: Name: NameFull: Bruno R – PersonEntity: Name: NameFull: Mercier F – PersonEntity: Name: NameFull: Vatakuti S – PersonEntity: Name: NameFull: Curle P – PersonEntity: Name: NameFull: Jamois C IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2024 Oct Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1532-6535 Numbering: – Type: volume Value: 116 – Type: issue Value: 4 Titles: – TitleFull: Clinical pharmacology and therapeutics Type: main |
| ResultId | 1 |